Polymatech begins domestic manufacturing of vein finder devices
CHENNAI: Polymatech Electronics Limited today announced a landmark milestone in India’s medical device sector with the successful registration and commencement of domestic manufacturing of its Vein Finder devices in accordance…
CDSCO brings in guidelines and SOPs on compounding of offences
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has released the guidelines and Standard Operating Procedures (SOPs) related to the compounding of offences under the Drugs and Cosmetics (Compounding…
DoP includes member of HTAIn in expert committee on pricing of drugs
New Delhi: Department of Pharmaceuticals (DoP) has added an expert representative from the Health Technology Assessment of India (HTAIn) under the Department of Health Research (DHR) as a member of…
Ayush and herbal products exports decline 33% in October
New Delhi: Exports of Ayush and herbal products have reported a decline of 33% during the month of October, compared to the same month of previous fiscal year. This is following…
Lupin Ramps Up Strategy to Counter U.S. Tariff Threat, Posts 52% Profit Surge
Mumbai, August 7, 2025 — Indian pharmaceutical giant Lupin is drawing up a multi-pronged strategy to navigate the looming threat of U.S. tariffs, while celebrating a robust 52% year-on-year surge…
Motilal Oswal Flags 9–11% Pharma Growth in India by FY 26; Recommends Five Stocks
Motilal Oswal Wealth Management projects India’s pharmaceutical sector to grow at 9–11% by fiscal 2026 and has spotlighted five pharma and healthcare stocks—Lupin, Mankind Pharma, Piramal Pharma, IPCA Labs, and…
Lincoln Pharma posts Rs 11.62 cr profit for Jan-Mar; revenue at Rs 161 cr
Lincoln Pharmaceuticals on Thursday reported a net profit of Rs 11.62 crore for the March quarter of 2024-25 and said it is building a portfolio in lifestyle and chronic segments,…
Lupin to boost complex generics in US, EU; eyes chronic growth in India
Lupin, which plans to develop the specialty business, is eyeing higher revenue share from its complex generics portfolios in the US and Europe. Moreover, with a pipeline of over 200…















